# BioStem Technologies, Inc. (BSEM)

> Source: Nexqual · https://nexqual.com/BSEM · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, BioStem Technologies, Inc. (BSEM), nexqual.com/BSEM" · informational, not investment advice.

**Price:** USD 2.04 (-3.32% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.11 · day 1.88–2.3 · 52w 1.88–8.4 · market cap $38.1M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 7 (range 7–7).
- Total return with dividends: 1Y -56.7% vs S&P 500 +18.1%; 5Y +45.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.43, revenue estimate $7.2M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 7 (low 7, high 7).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -56.7% | +45.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -56.8% | +7.8% |
| Volatility (annualized) | 115.1% | 110.7% |
| Max drawdown | -75.1% (Jan 2026→Oct 2026) | -91.0% (Nov 2024→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/BSEM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt